These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 38962016)

  • 1. Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment.
    Li X; Zhang C; Yue W; Jiang Y
    Front Immunol; 2024; 15():1362120. PubMed ID: 38962016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression.
    Tsui YM; Tian L; Lu J; Ma H; Ng IO
    Cancer Lett; 2024 Aug; 597():217084. PubMed ID: 38925362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cell Initiation by Tumor-Derived Extracellular Vesicles.
    Afify SM; Hassan G; Yan T; Seno A; Seno M
    Methods Mol Biol; 2022; 2549():399-407. PubMed ID: 33755909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The key roles of cancer stem cell-derived extracellular vesicles.
    Su C; Zhang J; Yarden Y; Fu L
    Signal Transduct Target Ther; 2021 Mar; 6(1):109. PubMed ID: 33678805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Yin and Yang of tumour-derived extracellular vesicles in tumour immunity.
    Yamauchi T; Moroishi T
    J Biochem; 2021 Mar; 169(2):155-161. PubMed ID: 33226400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives.
    Scioli MG; Terriaca S; Fiorelli E; Storti G; Fabbri G; Cervelli V; Orlandi A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.
    Müller L; Tunger A; Plesca I; Wehner R; Temme A; Westphal D; Meier F; Bachmann M; Schmitz M
    Front Immunol; 2020; 11():140. PubMed ID: 32117287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles in immunomodulation and tumor progression.
    Marar C; Starich B; Wirtz D
    Nat Immunol; 2021 May; 22(5):560-570. PubMed ID: 33753940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Stem Cells and Their Vesicles, Together with Other Stem and Non-Stem Cells, Govern Critical Cancer Processes: Perspectives for Medical Development.
    Meldolesi J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity.
    Chulpanova DS; Rizvanov AA; Solovyeva VV
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages and cancer stem cells: a malevolent alliance.
    Allavena P; Digifico E; Belgiovine C
    Mol Med; 2021 Sep; 27(1):121. PubMed ID: 34583655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation.
    Grange C; Tapparo M; Tritta S; Deregibus MC; Battaglia A; Gontero P; Frea B; Camussi G
    BMC Cancer; 2015 Dec; 15():1009. PubMed ID: 26704308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell-immune cell crosstalk in tumour progression.
    Bayik D; Lathia JD
    Nat Rev Cancer; 2021 Aug; 21(8):526-536. PubMed ID: 34103704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cancer stem cell-derived extracellular vesicles in cancer progression and metastasis.
    Naghibi AF; Daneshdoust D; Taha SR; Abedi S; Dehdezi PA; Zadeh MS; Dokoohaki F; Soleymani-Goloujeh M
    Pathol Res Pract; 2023 Jul; 247():154558. PubMed ID: 37245267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
    Ma Y; Lv H; Xing F; Xiang W; Wu Z; Feng Q; Wang H; Yang W
    Front Med; 2024 Jun; 18(3):430-445. PubMed ID: 38600350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells.
    Ingavle G; Das M
    ACS Biomater Sci Eng; 2022 Nov; 8(11):4673-4696. PubMed ID: 36194142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles in the tumor immune microenvironment.
    Hou PP; Chen HZ
    Cancer Lett; 2021 Sep; 516():48-56. PubMed ID: 34082025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
    Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
    J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How cancer cells dictate their microenvironment: present roles of extracellular vesicles.
    Naito Y; Yoshioka Y; Yamamoto Y; Ochiya T
    Cell Mol Life Sci; 2017 Feb; 74(4):697-713. PubMed ID: 27582126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.